Haleon (LON:HLN) Trading Up 0.4% – Still a Buy?

Haleon plc (LON:HLN) shares shot up 0.4% during trading on Friday . The stock traded as high as GBX 383.50 ($4.84) and last traded at GBX 381.97 ($4.82). 19,355,100 shares traded hands during trading, a decline of 1% from the average session volume of 19,493,533 shares. The stock had previously closed at GBX 380.60 ($4.80).

Haleon Price Performance

The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 54.18. The stock has a market cap of £34.53 billion, a P/E ratio of 3,183.08, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The business has a 50-day simple moving average of GBX 374.30 and a 200 day simple moving average of GBX 362.40.

Insider Transactions at Haleon

In other Haleon news, insider Dawn Allen sold 74,679 shares of Haleon stock in a transaction on Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.70), for a total value of £277,805.88 ($350,632.18). Also, insider Alan Stewart acquired 33,923 shares of the business’s stock in a transaction dated Wednesday, November 6th. The shares were bought at an average cost of GBX 368 ($4.64) per share, for a total transaction of £124,836.64 ($157,562.34). Corporate insiders own 10.74% of the company’s stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.